Find Clinical Trials | Cedars-Sinai

15 results found

Lung

Biomarker-Driven Therapies and Immunotherapies in Non-Small Cell Lung Cancer

This study focuses on patients with non-small cell lung cancer. The purpose is to study tumor tissue to determine whether a targeted or immunotherapy treatment will have an effect on specific genes and proteins in ...

Lung Cancer, Non-small cell

Osimertinib and Carotuximab in Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

The purpose of this study is to examine the safety and effectiveness of an experimental combination therapy of osimertinib (standard drug) with carotuximab (investigational study drug) in patients who are diagnosed with EGFR-mutated, non-small cell ...

Lung

Trastuzumab Deruxtecan in Non-Small Cell Lung Cancer

This study focuses on individuals who have unresectable, locally advanced or metastatic lung cancer with a mutation on the human epidermal growth factor receptor 2 (HER2). HER2 is a protein found on the surface of ...

Lung Cancer, Non-small cell

IOV-4001 in Melanoma or Non-Small-Cell Lung Cancer

The purpose of this study is to determine whether an investigational drug called IOV-4001 is safe and beneficial in the treatment of patients with unresectable or metastatic melanoma or advanced non-small cell lung cancer (NSCLC). ...

Breast cancer, Colon cancer, Lung Cancer, Melanoma, Rectal Cancer, Solid ...

GV20-0251 in Advanced and/or Refractory Solid Tumor Malignancies

The purpose of the study is to determine whether an experimental drug called GV20-0251 is safe and tolerable in patients with solid tumors that have not been successfully treated with standard therapies. GV20-0251 is a ...